We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Highly Aligned Nanofibers Developed for Tissue Engineering Applications

By LabMedica International staff writers
Posted on 10 Mar 2014
Print article
Image: Highly aligned nanofibers created by fibroblasts form biological scaffolding that could prove an ideal foundation for engineered tissues. Stem cells placed on the scaffolding thrived, and it had the added advantage of provoking a very low immune response (Photo courtesy of Dr. Feng Zhao, Michigan Technological University).
Image: Highly aligned nanofibers created by fibroblasts form biological scaffolding that could prove an ideal foundation for engineered tissues. Stem cells placed on the scaffolding thrived, and it had the added advantage of provoking a very low immune response (Photo courtesy of Dr. Feng Zhao, Michigan Technological University).
A team of biomedical engineers has constructed a uniform highly aligned nanoscale fibrous scaffolding from extracellular matrix (ECM) naturally deposited by fibroblasts to be used for potential tissue engineering applications.

When placed in contact with ECM obtained from epithelial cells or fibroblasts, cells attach quickly, exhibit high plating and cloning efficiencies, proliferate rapidly, reach a high saturation density, exhibit lower requirements for serum and added growth factors, respond better to physiologically occurring hormones, express differentiated functions, have longer life span, undergo flattening and morphological changes, and have better plating consistency. Such cells adopt growth characteristics, morphological appearance, and biological responses that are not expressed when the same cells are maintained on artificial substrata (plastic, glass), even if coated with isolated constituents of ECM such as purified collagen or glycoproteins.

Investigators at Michigan Technological University (Houghton, USA) used synthetic nanogratings (130 nanometers in depth) to direct the growth of human dermal fibroblasts for up to eight weeks, resulting in a uniform 70 micrometer-thick fibroblast cell sheet with highly aligned cells and ECM nanofibers. A natural ECM scaffolding with uniformly aligned nanofibers about 78 nanometers in diameter was generated after removing the cellular components from the fibroblast sheet.

In a report published in the January 29, 2014, online edition of the journal Advanced Functional Materials the investigators demonstrated the excellent capacity of the ECM-scaffolding in directing and supporting alignment and proliferation of reseeded human mesenchymal stem cells (hMSCs) along the underlying fibers. Furthermore, the aligned ECM scaffolding induced a significantly lower immune response compared to its unaligned counterpart, as detected by proinflammatory cytokines secreted from macrophages.

“The cells did the work,” said senior author Dr. Feng Zhao, assistant professor of biomedical engineering at Michigan Technological University. “The material they made is quite uniform, and of course it is completely biological. We think this has great potential. I think we could use this to engineer softer tissues, like skin, blood vessels, and muscle.”

Related Links:

Michigan Technological University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.